🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This protocol is an international, multicenter, comparative, open and rando...
Status
Unknown
Location
Hospital Universitário Clementino Fraga Filho
Start Date
2007-01
Trial ID
NCT01532856
Multicentric study, open, single arm, designed to evaluate the efficacy(res...
Status
Completed
Location
Hospital Morales Messeguer
Start Date
2007-01
Trial ID
NCT00652041
Treatments Being Tested
RATIONALE: Giving thalidomide together with prednisone and cyclophosphamide...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00445900
To explore the effectiveness and safety of thalidomide, cyclophosphamide an...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2017-01-01
Trial ID
NCT03043105
Treatments Being Tested
Primary Objective: Evaluate the clinical activity of the RT-PEPC combinati...
Status
Completed
Location
Weill Medical College of Cornell University
Start Date
2004-11
Trial ID
NCT00151281
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of GDPT re...
Status
Completed
Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Start Date
2011-08
Trial ID
NCT01664975
Treatments Being Tested
Due to economic reasons, thalidomide is still widely used as a first line d...
Status
Unknown
Location
Jinling Hospital
Start Date
2012-04
Trial ID
NCT02248428
Treatments Being Tested
This study is a multicenter, single-arm, non-randomized, open-label trial d...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2026-08-01
Trial ID
NCT07746245
Treatments Being Tested
This is a multicenter, open-label, non-randomized, multi-cohort study to ev...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2024-12-31
Trial ID
NCT07195799
This pooled analysis will assess data from the Phase 3 belimumab registrati...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT01914770
Treatments Being Tested